LLY vs MSFT
AI-powered side-by-side analysis. Updated every 2 hours.
Divergence: LLY is bullish while MSFT is neutral. Diverging directions between related stocks can signal sector rotation or company-specific catalysts.
LLY surges with FDA approval and strong 2025 growth
- • 2025 revenue rose 45% to $65.2 billion
- • Zepbound revenue $13.5 billion, up 175% YoY
- • Foundayo received FDA approval on April 1, 2026
Microsoft Azure Backlog Surges to $625B
- • Q2 FY2026 EPS $4.14 (7.57% beat)
- • Azure growth 39% YoY
- • Commercial backlog surged 110% to $625 billion
How This Works
The Read analyzes 50+ financial sources every 2 hours and maintains AI-scored positions on 40+ stocks. Each entity is independently evaluated based on insider activity, analyst ratings, earnings data, SEC filings, and news signals. See our track record.
This comparison updates automatically whenever either stock's analysis changes. Every prediction is timestamped and scored against real prices.
More Comparisons
Explore more